camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
Keytruda (pembrolizumab) - Merck (MSD)
https://www.abstractsonline.com/pp8/#!/10517/presentation/16648
 
Igor Puzanov, Christopher T. Chen, Patricia LoRusso, Kyriakos P. Papadopoulos, Shivaani Kummar, Erika Hamilton, Yvan LeBruchec, Karin Havenith, Serafino Pantano, Marie Toukam, Jens Wuerthner, Joseph Boni
 
Mar 9, 2022
 
Prev Next